ICD-10-CM Diagnosis Code C08.9 - Malignant neoplasm of major salivary gland, unspecified (original) (raw)
ICD List 2025-2026 Edition
- Home
- ICD-10-CM Codes
- C00–D49
- C00-C14
- C08
- 2026 ICD-10-CM Code C08.9
Malignant neoplasm of major salivary gland, unspecified
ICD-10-CM Code:
C08.9
ICD-10 Code for:
Malignant neoplasm of major salivary gland, unspecified
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Chronic
Code Navigator:
C08.9 is a billable diagnosis code used to specify a medical diagnosis of malignant neoplasm of major salivary gland, unspecified. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2025 through September 30, 2026.
The following anatomical sites found in the Table of Neoplasms reference this diagnosis code given the correct histological behavior: Neoplasm, neoplastic salivary gland or duct (major) or Neoplasm, neoplastic salivary gland or duct (major) overlapping lesion or Neoplasm, neoplastic salivary gland or duct (major) pluriglandular .
Unspecified diagnosis codes like C08.9 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.
- Code Information
- Approximate Synonyms
- Clinical Classification
- Tabular List of Diseases and Injuries
- Index to Diseases and Injuries References
- Diagnostic Related Groups Mapping
- Convert to ICD-9 Code
- Table of Neoplasms
- Patient Education
- Other Codes Used Similar Conditions
- Code History
- Neoplasms
C00–D49
The following list of clinical terms are approximate synonyms, alternative descriptions, or common phrases that might be used by patients, healthcare providers, or medical coders to describe the same condition. These synonyms and related diagnosis terms are often used when searching for an ICD-10 code, especially when the exact medical terminology is unclear. Whether you're looking for lay terms, similar diagnosis names, or common language alternatives, this list can help guide you to the correct ICD-10 classification.
- Adenoid cystic carcinoma of salivary gland
- Malignant epithelial neoplasm of salivary gland
- Malignant mixed tumor of salivary gland
- Malignant neoplasm of major salivary gland
- Malignant neoplasm of oral cavity and lip and salivary gland
- Malignant neoplasm of oral cavity and lip and salivary gland
- Malignant neoplasm of salivary gland
- Mucoepidermoid carcinoma of salivary gland
- Neoplasm of oral cavity and lip and salivary gland
- Neoplasm of oral cavity and lip and salivary gland
- Neoplasm of salivary gland duct
- Overlapping malignant neoplasm of major salivary gland
- Overlapping malignant neoplasm of oral cavity and lip and salivary gland
- Overlapping neoplasm of oral cavity and lip and salivary gland
- Polymorphous low grade adenocarcinoma of salivary gland
- Primary adenoid cystic carcinoma of salivary gland
- Primary carcinoma ex pleomorphic adenoma of salivary gland
- Primary malignant mixed tumor of salivary gland
- Primary malignant neoplasm of major salivary gland
- Primary malignant neoplasm of salivary gland duct
- Primary mucoepidermoid carcinoma of salivary gland
- Primary polymorphous low grade adenocarcinoma of salivary gland
Clinical Classifications group individual ICD-10-CM diagnosis codes into broader, clinically meaningful categories. These categories help simplify complex data by organizing related conditions under common clinical themes.
They are especially useful for data analysis, reporting, and clinical decision-making. Even when diagnosis codes differ, similar conditions can be grouped together based on their clinical relevance. Each category is assigned a unique CCSR code that represents a specific clinical concept, often tied to a body system or medical specialty.
CCSR Code: NEO004
Inpatient Default: Y - Yes, default inpatient assignment for principal diagnosis or first-listed diagnosis.
Outpatient Default: Y - Yes, default outpatient assignment for principal diagnosis or first-listed diagnosis.
The following annotation back-references for this diagnosis code are found in the injuries and diseases index. The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10-CM code(s).
- - Adenocarcinoma - See Also: Neoplasm, malignant, by site;
- - basal cell
* - unspecified site - C08.9
- - basal cell
- - Adenoma - See Also: Neoplasm, benign, by site;
- - pleomorphic
* - carcinoma in - See: Neoplasm, salivary gland, malignant;
* - unspecified site - C08.9
- - pleomorphic
References found for this diagnosis code in the External Cause of Injuries Index:
- Adenocarcinoma
- basal cell
- unspecified site
- basal cell
- Adenoma
- pleomorphic
- carcinoma in
- unspecified site
- carcinoma in
- pleomorphic
Below are the ICD-9 codes that most closely match this ICD-10 code, based on the General Equivalence Mappings (GEMs). This ICD-10 to ICD-9 crosswalk tool is helpful for coders who need to reference legacy diagnosis codes for audits, historical claims, or approximate code comparisons.
ICD-9-CM: 142.8
Approximate Flag - The approximate mapping means this ICD-10 code does not have an exact ICD-9 equivalent. The matched code is the closest available option, but it may not fully capture the original diagnosis or clinical intent.
ICD-9-CM: 142.9
Approximate Flag - The approximate mapping means this ICD-10 code does not have an exact ICD-9 equivalent. The matched code is the closest available option, but it may not fully capture the original diagnosis or clinical intent.
This code is referenced in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.
Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.
Filter table of neoplasms:
| Neoplasm, neoplastic | Malignant Primary | Malignant Secondary | CaInSitu | Benign | Uncertain Behavior | Unspecified Behavior |
|---|---|---|---|---|---|---|
| »Neoplasm, neoplastic »salivary gland or duct (major) | C08.9 | C79.89 | D00.00 | D11.9 | D37.039 | D49.0 |
| »Neoplasm, neoplastic »salivary gland or duct (major) »overlapping lesion | C08.9 | |||||
| »Neoplasm, neoplastic »salivary gland or duct (major) »pluriglandular | C08.9 | C79.89 | D00.00 | D11.9 | D37.039 | D49.0 |
Salivary Gland Cancer
Your salivary glands make saliva - sometimes called spit - and empty it into your mouth through openings called ducts. Saliva makes your food moist, which helps you chew and swallow. It helps you digest your food. It also cleans your mouth and contains antibodies that can kill germs.
Salivary gland cancer is a type of head and neck cancer. It is rare. It may not cause any symptoms, or you could notice:
- A lump in your ear, cheek, jaw, lip, or inside the mouth
- Fluid draining from your ear
- Trouble swallowing or opening the mouth widely
- Numbness, weakness, or pain in your face
Doctors diagnose salivary gland cancer using a physical exam, imaging tests, and a biopsy. Treatment can include surgery, radiation therapy, and/or chemotherapy.
NIH: National Cancer Institute
FY 2026 - No Change, effective from 10/1/2025 through 9/30/2026
FY 2025 - No Change, effective from 10/1/2024 through 9/30/2025
FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.
